Lyophilized Progenitor Tenocyte Extracts: Sterilizable Cytotherapeutic Derivatives with Antioxidant Properties and Hyaluronan Hydrogel Functionalization Effects
-
Published:2023-01-10
Issue:1
Volume:12
Page:163
-
ISSN:2076-3921
-
Container-title:Antioxidants
-
language:en
-
Short-container-title:Antioxidants
Author:
Laurent Alexis, Porcello AlexandreORCID, Jeannerat Annick, Peneveyre Cédric, Coeur Agathe, Abdel-Sayed PhilippeORCID, Scaletta Corinne, Michetti Murielle, de Buys Roessingh AnthonyORCID, Jordan OlivierORCID, Allémann EricORCID, Raffoul WassimORCID, Hirt-Burri NathalieORCID, Applegate Lee AnnORCID
Abstract
Cultured primary progenitor tenocytes in lyophilized form were previously shown to possess intrinsic antioxidant properties and hyaluronan-based hydrogel viscosity-modulating effects in vitro. The aim of this study was to prepare and functionally characterize several stabilized (lyophilized) cell-free progenitor tenocyte extracts for inclusion in cytotherapy-inspired complex injectable preparations. Fractionation and sterilization methods were included in specific biotechnological manufacturing workflows of such extracts. Comparative and functional-oriented characterizations of the various extracts were performed using several orthogonal descriptive, colorimetric, rheological, mechanical, and proteomic readouts. Specifically, an optimal sugar-based (saccharose/dextran) excipient formula was retained to produce sterilizable cytotherapeutic derivatives with appropriate functions. It was shown that extracts containing soluble cell-derived fractions possessed conserved and significant antioxidant properties (TEAC) compared to the freshly harvested cellular starting materials. Progenitor tenocyte extracts submitted to sub-micron filtration (0.22 µm) and 60Co gamma irradiation terminal sterilization (5–50 kGy) were shown to retain significant antioxidant properties and hyaluronan-based hydrogel viscosity modulating effects. Hydrogel combination products displayed important efficacy-related characteristics (friction modulation, tendon bioadhesivity) with significant (p < 0.05) protective effects of the cellular extracts in oxidative environments. Overall, the present study sets forth robust control methodologies (antioxidant assays, H2O2-challenged rheological setups) for stabilized cell-free progenitor tenocyte extracts. Importantly, it was shown that highly sensitive phases of cytotherapeutic derivative manufacturing process development (purification, terminal sterilization) allowed for the conservation of critical biological extract attributes.
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference82 articles.
1. Human fetal progenitor tenocytes for regenerative medicine;Grognuz;Cell Transpl.,2016 2. Stability enhancement using hyaluronic acid gels for delivery of human fetal progenitor tenocytes;Grognuz;Cell Med.,2016 3. Laurent, A., Abdel-Sayed, P., Grognuz, A., Scaletta, C., Hirt-Burri, N., Michetti, M., de Buys Roessingh, A.S., Raffoul, W., Kronen, P., and Nuss, K. (2021). Industrial development of standardized fetal progenitor cell therapy for tendon regenerative medicine: Preliminary safety in xenogeneic transplantation. Biomedicines, 9. 4. Laurent, A., Porcello, A., Fernandez, P.G., Jeannerat, A., Peneveyre, C., Abdel-Sayed, P., Scaletta, C., Hirt-Burri, N., Michetti, M., and de Buys Roessingh, A. (2021). Combination of hyaluronan and lyophilized progenitor cell derivatives: Stabilization of functional hydrogel products for therapeutic management of tendinous tissue disorders. Pharmaceutics, 13. 5. Regulation of advanced therapy medicinal products in Europe and the role of academia;Pearce;Cytotherapy,2014
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|